Dietary supplementation roles in concussion management: A systematic review.
- 2025-04
- Tzu chi medical journal 37(2)
- Andre Marolop Pangihutan Siahaan
- Alvin Ivander
- Bahagia Wilibrordus Maria Nainggolan
- Ruth Hasian Nami Siagian
- Lidya Veronika
- Natanael Ramoti
- PubMed: 40321955
- DOI: 10.4103/tcmj.tcmj_241_24
Study Design
- Type
- Review
- Population
- human studies on using dietary supplements as adjunctive therapy in the management of concussion
- Methods
- Systematic review following PRISMA guidelines, search strategy based on PICO framework, narrative synthesis, classification of acute (≤7 days) and nonacute interventions
Concussion, one of the most common types of mild traumatic brain injury, remains a global problem that poses substantial effects on individuals, families, and society. When dealing with concussion, clinicians primarily focus on symptomatic treatment and modified activity with no established therapies specifically addressing the underlying pathophysiological changes. In recent years, there has been a growing increase in attention to the effectiveness of dietary supplements (DS) and nutritional interventions as adjunctive therapy options for concussion. Hence, this review aims to comprehensively explore the existing human studies on using DS as adjunctive therapy in the management of concussion. This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. The search strategy was created based on the population, intervention, comparison, outcome framework. The findings are conveyed narratively and analyzed according to the timing of the intervention. DS administered within 7 days of onset were classified as acute interventions, while those given after this period were classified as nonacute interventions. After screening, we identified 21 reports for 19 studies involving 13 DS. Thirteen DS were included in this review. Notably, omega-3 polyunsaturated fatty acids were the most extensively studied and accounted for 23.81% of studies, followed by melatonin and pine bark extract (19.05% and 9.5%). At least 13 supplements were identified in clinical studies, with 77% demonstrating favorable outcomes. However, none of the interventions reviewed offer strong enough evidence to justify regular use in clinical practice.
Research Insights
13 supplements were identified in clinical studies, with 77% demonstrating favorable outcomes.
- Effect
- Beneficial
- Effect size
- Small
none of the interventions reviewed offer strong enough evidence to justify regular use in clinical practice.
- Effect
- Neutral
- Effect size
- Small